Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Cash from Investing Activities (2022 - 2025)

Historic Cash from Investing Activities for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to -$269.0 million.

  • GE HealthCare Technologies' Cash from Investing Activities fell 1208.33% to -$269.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.0 billion, marking a year-over-year decrease of 1455.14%. This contributed to the annual value of -$1.0 billion for FY2025, which is 1455.14% down from last year.
  • According to the latest figures from Q4 2025, GE HealthCare Technologies' Cash from Investing Activities is -$269.0 million, which was down 1208.33% from -$148.0 million recorded in Q3 2025.
  • Over the past 5 years, GE HealthCare Technologies' Cash from Investing Activities peaked at -$84.0 million during Q2 2023, and registered a low of -$407.0 million during Q1 2025.
  • For the 4-year period, GE HealthCare Technologies' Cash from Investing Activities averaged around -$182.3 million, with its median value being -$142.5 million (2024).
  • In the last 5 years, GE HealthCare Technologies' Cash from Investing Activities crashed by 31547.62% in 2024 and then soared by 3610.32% in 2025.
  • Quarter analysis of 4 years shows GE HealthCare Technologies' Cash from Investing Activities stood at -$95.0 million in 2022, then grew by 7.37% to -$88.0 million in 2023, then plummeted by 172.73% to -$240.0 million in 2024, then decreased by 12.08% to -$269.0 million in 2025.
  • Its last three reported values are -$269.0 million in Q4 2025, -$148.0 million for Q3 2025, and -$223.0 million during Q2 2025.